ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

ACS Lists Challenges For Global Tobacco Control

January 22, 2010

In Brief: New Clinical Education Program Guidelines Due; Maryland Has First Mammography Screening Law

May 30, 1986

Robert Day Advocates NCI Payment for Investigator Salaries

May 7, 1999

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004

In Brief: NCI Cutting Back Support For Training Medical, Pediatric Oncologists; Clark Receives ACS Award

December 5, 1980

Clinical Trials Approved By NCI

October 31, 2003